Celanese Corp. 10-Q Summary: Period Ended June 30, 2005
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2005, for Celanese Corporation (the "Successor"). The company is a global industrial chemicals manufacturer formed following the acquisition of Celanese AG ("CAG" or the "Predecessor") in April 2004. The financial statements reflect the application of purchase accounting for the CAG acquisition and preliminary purchase price adjustments for the February 2005 acquisition of the Vinamul emulsions business. The Successor's results are not directly comparable to the Predecessor's historical results due to differences in accounting basis.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2005 | Six Months Ended June 30, 2005 |
|---|---|---|
| Net Sales | $1,517 million | $3,026 million |
| Operating Profit | $152 million | $318 million |
| Net Earnings | $67 million | $57 million |
| Net Earnings Available to Common Shareholders | $65 million | $53 million |
| Diluted EPS | $0.39 | $0.35 |
| Operating Margin | 10.0% | 10.5% |
| Interest Expense | $68 million | $244 million |
| Cash and Cash Equivalents | $959 million (as of June 30, 2005) | N/A |
| Total Debt | $3,393 million (as of June 30, 2005) | N/A |
| Net Debt | $2,434 million (as of June 30, 2005) | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 23% year-over-year in Q2 2005, driven by higher pricing (15%), the inclusion of the Vinamul business (8%), and favorable currency movements (2%).
- Profitability Turnaround: The company reported net earnings of $67 million in Q2 2005, a significant improvement from a net loss of $125 million in Q2 2004. The prior year loss included $71 million in deferred financing costs related to bridge loan prepayments.
- Operating Profit: Operating profit rose to $152 million from $25 million in the prior year quarter, benefiting from margin expansion, productivity improvements, and the absence of a $49 million non-cash inventory purchase accounting adjustment recorded in 2004.
- Special Charges: Q2 2005 included $27 million in special charges, primarily due to a $24 million asset impairment related to the decision to divest the Cyclo-olefin Copolymer (COC) business. This compares to $1 million in special charges (net of recoveries) in Q2 2004.
- Interest Expense: Interest expense decreased to $68 million in Q2 2005 from $130 million in Q2 2004, as the prior year included significant one-time refinancing costs.
Guidance, Outlook, and Risks
Outlook: Management expects global GDP to remain strong in the second half of 2005. However, pricing may be impacted as the acetyls market absorbs industry capacity expansions. The company anticipates the July 2005 acquisition of Acetex Corporation will be accretive in the second half of the year. The company expects to incur expenses for restructuring and portfolio optimization.
Dividends: The company adopted a policy to pay an annual dividend of $0.16 per share on Series A common stock (1% of the IPO price). The first quarterly payment of $0.04 per share was made on August 11, 2005. Preferred stock dividends of 4.25% per annum are cumulative.
Risks and Contingencies:
- Legal Proceedings: Significant litigation includes "Plumbing Actions" (product liability regarding Celcon plumbing systems) with remaining accruals of $71 million, and "Sorbates Antitrust Actions" with remaining accruals of $130 million (partially indemnified by Hoechst).
- Domination Agreement: The company is subject to a Domination Agreement with CAG minority shareholders, requiring fair cash compensation and guaranteed fixed annual payments. Special award proceedings initiated by minority shareholders were dismissed in March 2005 but have been appealed.
- Internal Controls: The company disclosed two material weaknesses in internal controls over financial reporting as of June 30, 2005, related to hedge effectiveness assessment and the ability to research complex accounting matters. Consequently, disclosure controls and procedures were deemed ineffective.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress made in addressing the two material weaknesses in internal controls identified by KPMG and the company's management.
- Acetex Integration: Monitor the integration of the Acetex Corporation acquisition (closed July 2005) and the planned redemption of Acetex's senior notes in August 2005.
- Legal Reserves: Track developments in the Plumbing Actions and Sorbates Antitrust cases to assess the adequacy of current accruals ($71 million and $130 million, respectively).
- Debt Covenants: Confirm continued compliance with debt covenants, particularly given the high leverage (Net Debt of $2.4 billion) and significant debt service requirements.
- Dividend Sustainability: Assess cash flow generation relative to the new dividend policy ($25 million annualized on common stock plus preferred dividends) and debt obligations.